Left sidebar

Lorem Ipsum is simply dummy text of the printing.
Posted by The Analyst | 29 July 2019 | Breaking News
Boy, six, among those killed by gunman at California garlic festival

A six-year-old boy was among the dead after a gunman cut through a fence to avoid security and opened fire at Northern California's popular Gilroy Garlic Festival.

Continue Reading
Posted by The Analyst | 29 July 2019 | Breaking News
China stands by Hong Kong police and blames West for unrest

China has blamed Western forces and defended police conduct in remarks about Hong Kong after the city endured another weekend of violent clashes between protesters and police.

Continue Reading
Posted by The Analyst | 29 July 2019 | Breaking News
Rhino horns worth €3.5 million seized in Vietnam

Vietnam's customs authority has confiscated 125 kilograms (275lbs) of rhino horns worth up to €3.5m.

Continue Reading
Posted by The Analyst | 29 July 2019 | Science & Tech
Esports injuries real for pros and at-home gamer, from finger sprains to collapsed lungs

From minor injuries to collapsed lungs, both professional esport athletes and recreational players see the physical toll gaming takes on their body.

Continue Reading
Posted by The Analyst | 29 July 2019 | Business
JP Morgan, Barclays, RBS among big banks facing UK class action over Forex rigging

Major global banks including Barclays, JP Morgan, RBS, UBS, and Citigroup are being sued by investors over allegations they rigged the global foreign exchange (Forex) market. Read Full Article at RT.com

Continue Reading
Posted by The Analyst | 29 July 2019 | Breaking News
London Stock Exchange Group shares surge on Refinitiv takeover talks

Shares in London Stock Exchange Group surged 15% higher on Monday after it confirmed talks to acquire data vendor Refinitiv, in a move that would create a financial information giant.

Continue Reading
Posted by The Analyst | 29 July 2019 | Breaking News
Pharmaceutical giant Pfizer to combine with Mylan

Pfizer is buying Mylan in an all-stock deal and combining the 10 billion US dollar generic pharmaceutical company with its own off-patent branded and generic business.

Continue Reading